Announcement, Our Impact 04.03.23 Share on Twitter Share on Facebook Share on LinkedIn PICI-affiliated Researchers Featured at #AACR23 Philip Greenberg, MD, will begin his term as president of the American Association for Cancer Research. Honorees include Carl H. June, MD; E. John Wherry, PhD; Robert D. Schreiber, PhD; and Andrea Schietinger, PhD. More than 20 investigators affiliated with the Parker Institute for Cancer Immunotherapy (PICI) will be featured at the American Association for Cancer Research (AACR) Annual Meeting 2023, April 14-19 in Orlando. Philip Greenberg, MD, (Twitter: @HutchGreenberg) of Fred Hutchinson Cancer Center will be installed as AACR president for the 2023-2024 term and will be at the April 18 “Meet the 2023-2024 AACR President” session. He has served as president-elect for the past year. Honorees include leaders of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania: Center Director Carl H. June, MD, (Twitter: @CarlHJune) who will receive the AACR Award for Lifetime Achievement in Cancer Research – a recognition of his groundbreaking work in developing the first gene-edited cell therapy for cancer and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer. Center Co-Director E. John Wherry, PhD, (Twitter: @EJohnWherry) who will receive the AACR-Cancer Research Institute (CRI) Lloyd J. Old Award in Cancer Immunology for outstanding and innovative research that has had a major impact on the cancer field and has the potential to stimulate new directions in cancer immunology. Two other PICI Network members also are being honored with lectureships: Robert D. Schreiber, PhD, of Washington University School of Medicine in St. Louis, who will deliver the AACR-Princess Takamatsu Memorial Lectureship on April 17. The lectureship award recognizes an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of Princess Takamatsu to multinational collaborations. Andrea Schietinger, PhD, of Memorial Sloan Kettering Cancer Center, who will deliver the AACR-Irving Weinstein Foundation Distinguished Lectureship on April 18. This award acknowledges an individual whose outstanding personal innovation in science and whose position as a thought leader in fields relevant to cancer research has the potential to inspire creative thinking and new directions in cancer research. PICI Network member Robert H. Vonderheide, MD, DPhil, of the University of Pennsylvania, is program committee chair of this year’s meeting. He will chair the opening and closing plenary sessions: “Advancing the Frontiers of Cancer Science and Medicine,” on April 16, and “AACR Annual Meeting 2023 Highlights: Vision for the Future,” on April 19 Beatriz M. Carreno, PhD, also of the University of Pennsylvania, will deliver a plenary presentation during the “Beating Kras: A 30-Year Overnight Sensation” session on April 15. Below are details about these and other sessions featuring PICI-affiliated investigators. Unless otherwise noted, each session will be at the Orange County Convention Center. Please note that programming is subject to change. For the most current information, visit the conference schedule or download the app. Follow the meeting live on Twitter using the hashtag #AACR23. Saturday, April 15 Session: ED053 – Fostering Entrepreneurship I: Commercializing Innovative Ideas – Where to Start? Panelist: Yvonne Y. Chen, PhD, University of California Los Angeles, Los Angeles Time: 8-9:30 a.m. Location: Room W315 Session: ED036 – Understanding Neutrophil Dynamics in Cancer: Mouse to Human and Back Again Time: 10-11:30 a.m. Location: Valencia BC Presenter: Taha Merghoub, PhD, (Twitter: @merghout) Weill Cornell Medicine Presentation: Immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants Time: 11-11:20 a.m. Session: ED046 – Recent Advances and Future Directions in Immunotherapeutic Approaches to Childhood Solid Malignancies Time: 2:30-4 p.m. Location: Tangerine Ballroom 3-4 (WF3-4) Presenter: Crystal L. Mackall, MD, (Twitter: @mackalllab) Stanford University Presentation: CAR T cells for children’s cancers Time: 3:30-3:50 p.m. Session: PL01 – Beating KRAS: A 30-Year Overnight Sensation Time: 4:15-6:15 p.m. Location: W Hall A2-3 Presenter: Beatriz M. Carreno, PhD Presentation: KRAS is personal: Just ask the immune system Time: 5:40-6:07 p.m. Sunday, April 16 Plenary Session: PL02 – Opening Plenary Session: Advancing the Frontiers of Cancer Science and Medicine Chairperson: Robert H. Vonderheide, MD, DPhil Time: 9:30-11:30 a.m. Location: W Hall A2-3 Session: CTPL01 – Harnessing the Immune System in the Clinic Time: 12:45-3:15 p.m. Location: Chapin Theater Discussant: Margaret Callahan, MD, PhD, Memorial Sloan Kettering Cancer Center Time: 1-1:10 p.m. Session: SY06 – Contributions of the Tumor Glycome to Immune Suppression and Immunotherapy Resistance and Opportunities for Therapeutic Intervention Chairperson: Avery D. Posey, PhD, (Twitter: @IAmDrDex) University of Pennsylvania Time: 1-2:30 p.m. Location: Room W224 Presenter: Avery D. Posey, PhD Presentation: Interactions between truncated O-glycans and the immune system, and opportunities for intervention Time: 1:55-2:15 p.m. Session: MS.CL07.01 – Immunotherapy Time: 3-5 p.m. Location: Room W414 Presenter: Zinaida Good, PhD, (Twitter: @GoodZinaida) Stanford University Presentation: 1128 – Lineage tracing of CAR T cells in patients with B cell malignancies Time: 4:07-4:22 p.m. Session: LE03 – AACR Award for Lifetime Achievement in Cancer Research Awardee and Invited Speaker: Carl H. June, MD Time: 4:30-5:15 p.m. Location: Valencia D Monday, April 17 Session: MG04 – Meet the Editors-in-Chief of Cancer Immunology Research: Robert D. Schreiber, PhD and Philip D. Greenberg, MD Discussants: Robert D. Schreiber, PhD, and Philip D. Greenberg, MD Time: 9:30-10:30 a.m. Location: Publications Booth 2743 – W Halls B-E1 Session: SY12 – T Cells and the Tumor Time: 10:15-11:45 a.m. Location: Valencia A Presenter: Ansuman T. Satpathy, MD, PhD, (Twitter: @satpathology) Stanford University Presentation: Enhancing T cell effector function in cancer Time: To be announced Session: MS.IM02.01 – From Cancer Immunology to Immunotherapy Chairperson: Taha Merghoub, PhD Time: 2:30-4:30 p.m. Location: Valencia A Session: LBMS01 – Minisymposium: Late-breaking Research Chairperson: Robert H. Vonderheide, MD, DPhil Time: 2:30-4:30 p.m. Location: Room W307 Session: LE11 – AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology Chairperson: Crystal L. Mackall, MD Awardee and Invited Speaker: E. John Wherry, PhD Time: 3:30-4:15 p.m. Location: Tangerine Ballroom 2 (WF2) Session: SS04 – AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors Time: 4:45-6:15 p.m. Location: Room W315 Presenter: Padmanee Sharma, MD, PhD, (Twitter: @PamSharmaMDPhD) The University of Texas MD Anderson Cancer Presentation: From the clinic to the lab: Investigating myeloid cells that drive resistance to immune checkpoint therapy Time: 5:17-5:39 p.m. Session: FO07 – CAR Cells: Which CAR to Drive? Time: 5-6:30 p.m. Location: Chapin Theater Presenter: Yvonne Y. Chen, PhD Presentation: Synthetic biology for CAR protein engineering Time: 5:05-5:20 p.m. Presenter: Christine E. Brown, PhD, City of Hope Presentation: CAR protein engineering: Practical considerations and functional implications? Time: 5:20-5:35 p.m. Session: LE15 – AACR-Princess Takamatsu Memorial Lectureship Time: 5:30-6:15 p.m. Location: Tangerine Ballroom 3-4 (WF3-4) Presenter: Robert D. Schreiber, PhD Presentation: The Complex Roles of CD4+ T Cells in Promoting or Inhibiting Immune Responses to Cancer Time: 5:40-6:15 p.m. Session: PAS06 – Navigating the Path to a Successful Career in Cancer Research Co-Chairperson: Katie M. Campbell, PhD, (Twitter: @CampKatiee) University of California, Los Angeles Time: 7-9 p.m. Location: Rosen Centre Hotel, Junior Ballroom F Tuesday, April 18 Session: ADT04 – Cancer Vaccines: Back to the Future Chairperson: Vinod P. Balachandran, MD, (Twitter: @TheVinodLab) Memorial Sloan Kettering Cancer Center Time: 10:15-11:45 a.m. Location: Tangerine Ballroom 3-4 (WF3-4) Presenter: Catherine J. Wu, MD, Dana-Farber Cancer Institute Presentation: Title to be announced Time: 10:20-10:40 a.m. Presenter: Vinod P. Balachandran, MD Presentation: Individualized mRNA neoantigen vaccines for pancreatic cancer Time: 10:40-11 a.m. Session: SY18 – Dharma Master Jiantai Symposium in Targeted Therapy: Cellular Therapies for Cancer Chairperson: Christopher A. Klebanoff, MD, (Twitter: @KlebanoffLab) Memorial Sloan Kettering Cancer Center Time: 12:30-2 p.m. Location: Tangerine Ballroom 2 (WF2) Presenter: Christopher A. Klebanoff, MD Presentation: Immunogenicity and therapeutic targeting of recurrently mutated ‘public’ neoantigens Time: 12:35-12:55 p.m. Session: ADT11 – Immune Profiling and Immune Health in Cancer Time: 12:30-2 p.m. Location: Tangerine Ballroom 3-4 (WF3-4) Presenter: E. John Wherry, PhD Presentation: Immune cells as ‘biosensors’ and the basis for immune health profiling of cancer and beyond Time: 1:25-1:45 p.m. Session: MG11 – Meet the 2023-2024 AACR President, Philip D. Greenberg, MD, FAACR Time: 1:30-2:30 p.m. Location: AACR Central – W Halls B-E1 Session: MS.IM01.02 – New Opportunities for Combinatorial Immunotherapies Co-Chairperson: Crystal L. Mackall, MD Time: 2:30-4:30 p.m. Location: Tangerine Ballroom 2 (WF2) Session: LE20 – AACR-Irving Weinstein Foundation Distinguished Lectureship Invited Speaker: Andrea Schietinger, PhD Time: 4:45-5:30 p.m. Location: Room W331 Session: FO11 – Driving Towards Rational Combination ICT Trials Moderator: Padmanee Sharma, MD, PhD Time: 5-6:30 p.m. Location: Chapin Theater Presenter: Padmanee Sharma, MD, PhD Presentation: Investigating mechanisms of response and resistance for the development of ICT combinations Time: 5:01-5:21 p.m. Session: FO05 – What Does a Biostatistician Really Think of Your Study and Why? Time: 5-6:30 p.m. Location: Room W311 A-D Presenter: Christopher Cabanski, PhD, PICI Presentation: Designing a clinical trial: best practices and pitfalls to avoid Time: 5:05-5:20 p.m. Wednesday, April 19 Session: SY19 – Engineered T Cells for Solid Tumors Time: 10:15-11:45 a.m. Location: Tangerine Ballroom 2 (WF2) Presenter: Kole Roybal, PhD, (Twitter: @KoleRoybal) University of California, San Francisco Presentation: Towards the development of synthetic immunity to cancer Time: 10:20-10:40 a.m. Presenter: Cristina Puig-Saus, PhD, University of California, Los Angeles Presentation: Engineering a potent T-cell response against solid tumors Time: 10:45-11:05 a.m. Session: PL06 – AACR Annual Meeting 2023 Highlights: Vision for the Future Chairperson: Robert H. Vonderheide, MD, DPhil Time: Noon-1:25 p.m. Location: Chapin Theater Related Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research